Semiconductor nanocrystal-aptamer bioconjugate probes for specific prostate carcinoma cell targeting

Felice Shieh; Laura Lavery; Chitai Ted Chu; Rebecca Richards-Kortum; Andrew D. Ellington; Brian A. Korgel

doi:10.1117/12.597249

28 April 2005 Semiconductor nanocrystal-aptamer bioconjugate probes for specific prostate carcinoma cell targeting

Felice Shieh, Laura Lavery, Chitai Ted Chu, Rebecca Richards-Kortum, Andrew D. Ellington, Brian A. Korgel

Proceedings Volume 5705, Nanobiophotonics and Biomedical Applications II; (2005) https://doi.org/10.1117/12.597249
Event: SPIE BiOS, 2005, San Jose, CA, United States

Abstract

Cancer of the prostate affects approximately 1 in 11 men. Current early screening for prostate cancer utilizes digital rectal examinations to detect anomalies in the prostate gland and blood test screenings for upregulated levels of prostate specific antigen (PSA). Many of these tests are invasive and can often be inconclusive as PSA levels may be heightened due to benign factors. Prostate specific membrane antigen (PSMA), a well-characterized integral membrane protein, is expressed in virtually all prostate cancers and often correlates with cancer aggressiveness. Therefore, it may be used as an indicator of cancer growth and metastases. PSMA-specific antibodies have been identified and conjugated to fluorescent markers for cancer cell targeting; however, both the antibodies and markers possess significant limitations in their pharmaceutical and diagnostic value. Here we report the use of semiconductor nanocrystals bioconjugated to PSMA-specific aptamer recognition molecules for prostate carcinoma cell targeting. The nanocrystal/aptamer bioconjugates are small biocompatible probes with the potential for color-tunability for multicolor imaging. Ongoing in vitro and in vivo research seeks to introduce these nanoparticle bioconjugates into medical diagnostics.

Citation Download Citation

Felice Shieh, Laura Lavery, Chitai Ted Chu, Rebecca Richards-Kortum, Andrew D. Ellington, and Brian A. Korgel "Semiconductor nanocrystal-aptamer bioconjugate probes for specific prostate carcinoma cell targeting", Proc. SPIE 5705, Nanobiophotonics and Biomedical Applications II, (28 April 2005); https://doi.org/10.1117/12.597249

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available